0001415889-24-023128.txt : 20240910 0001415889-24-023128.hdr.sgml : 20240910 20240910160507 ACCESSION NUMBER: 0001415889-24-023128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240910 FILED AS OF DATE: 20240910 DATE AS OF CHANGE: 20240910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Inrig Jula CENTRAL INDEX KEY: 0001902368 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36257 FILM NUMBER: 241290107 MAIL ADDRESS: STREET 1: C/O TRAVERE THERAPEUTICS, INC. STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Travere Therapeutics, Inc. CENTRAL INDEX KEY: 0001438533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262383102 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DR STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 888-969-7879 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DR STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Retrophin, Inc. DATE OF NAME CHANGE: 20130220 FORMER COMPANY: FORMER CONFORMED NAME: Desert Gateway, Inc. DATE OF NAME CHANGE: 20080625 4 1 form4-09102024_040901.xml X0508 4 2024-09-10 0001438533 Travere Therapeutics, Inc. TVTX 0001902368 Inrig Jula C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 false true false false CHIEF MEDICAL OFFICER 1 Common Stock 2024-09-10 4 S 0 684 12.98 D 61949 D This sale was made pursuant to a written plan adopted March 15, 2024 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units that vested on September 5, 2024. /s/ Elizabeth E. Reed, Attorney-in-Fact 2024-09-10